# A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

> **NCT06807424** · PHASE3 · RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 750 (estimated)

## Conditions studied

- Arthritis, Psoriatic

## Interventions

- **DRUG:** Icotrokinra
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06807424
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-09
- **Primary completion:** 2027-02-10
- **Final completion:** 2028-10-18
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06807424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06807424, "A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06807424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*